MedTrace Logo

A Cohort of Maternal Vascular Malperfusion-related FGR (CoMVMFGR)

NCT06104748 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-06-07

No results posted yet for this study

Summary

Based on a precise diagnostic standard process, through a multicenter study, we will establish a cohort focusing on placenta-mediated fetal growth restriction (FGR). Long-term follow-up will be conducted to seek predictive indicators for short-term and long-term adverse outcomes of maternal vascular malperfusion-related FGR (MVM-FGR).

Conditions

  • MVM-FGR

Sponsors & Collaborators

  • Shanghai First Maternity and Infant Hospital

    lead OTHER

Principal Investigators

  • Luming Sun, Doctor · Department of Fetal Medicine, Shanghai First Maternity and Infant Hospital

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-10
Primary Completion
2025-12-30
Completion
2025-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06104748 on ClinicalTrials.gov